查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1606754

药物发现资讯学市场：按解决方案、功能、最终用户、应用划分 - 2025-2030 年全球预测

Drug Discovery Informatics Market by Solutions (Services, Software), Functions (Docking, Libraries & Database Preparation, Molecular Modeling), End-User, Application - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 199 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计2023年药物发现资讯学市场规模为29亿美元，预计2024年将达到31.9亿美元，复合年增长率为9.92%，到2030年将达到56.4亿美元。

药物发现资讯学涉及应用计算、统计和资讯技术来改进药物发现过程。这种需求源于靶向生物活性化合物的巨大复杂性，以及对成本效率和加速药物发现过程的日益增长的需求。其应用范围包括药物标靶辨识、先导化合物搜寻、测定开发和虚拟筛检。最终用途包括製药公司、生物技术公司、受託研究机构和学术机构。

主要市场统计
基准年[2023] 29亿美元
预测年份 [2024] 31.9亿美元
预测年份 [2030] 56.4亿美元
复合年增长率（%） 9.92%

市场成长受到巨量资料分析、人工智慧和机器学习进步的显着影响，这些进步提高了药物发现过程中的预测准确性。个人化医疗的普及和云端基础的解决方案的日益采用进一步推动了这一增长。机会包括整合人工智慧和资讯学以实现精准医疗、共用分子资料的合作计划以及扩展到新兴市场。儘管存在这些机会，但挑战包括资讯学工具的高成本和资料管理的复杂性。严格的监管和资料隐私问题也为市场扩张带来了障碍。

可以在开发直觉的资料视觉化使用者介面、简化跨平台资料整合以及提高演算法的稳健性以实现更好的预测模型等领域促进创新。公司应该专注于建立可扩展的解决方案，以不断适应药物发现过程中产生的不断增长的资料量。我们也与学术机构和行业相关人员合作，共用知识和资源并促进创新。

该市场充满活力且竞争激烈，许多参与者为其快速发展做出了贡献。公司应优先考虑保持技术趋势的前沿，促进跨学科研究，并透过特定治疗领域的资讯学解决方案获得竞争优势。策略投资和创新合作的结合使公司能够有效应对药物发现资讯学的复杂性并推动市场扩张和成功。

市场动态：揭示快速发展的药物发现资讯学市场的关键市场洞察

供需的动态交互作用正在改变药物发现资讯学市场。透过了解这些不断变化的市场动态，公司可以准备好做出明智的投资决策、完善策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，并了解消费行为及其对製造成本的影响，并更清楚地了解对采购趋势的影响。

  • 市场驱动因素
    • 罕见疾病和孤儿病管理对精准医疗的需求不断增加
    • 政府对药物发现程序的有利支持
    • 生物资讯软体在药物发现和药物开发的使用增加
  • 市场限制因素
    • 开发生物资讯学基础设施的庞大成本
  • 市场机会
    • 药物发现资讯学开发的潜在研究投资
    • 将下一代技术整合到药物发现程序中
  • 市场挑战
    • 缺乏技术精湛、经验丰富的专业人员

波特五力：驾驭药物发现资讯学市场的策略工具

波特的五力框架是了解市场竞争格局的重要工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势、解决弱点并避免潜在的挑战，以确保更强大的市场地位。

PESTLE分析：了解药物发现资讯学市场的外部影响

外部宏观环境因素在塑造药物发现资讯学市场的绩效动态方面发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并帮助他们做出积极主动的决策。

市场占有率分析 了解药物发现资讯学市场的竞争状况

对药物发现资讯学市场的详细市场占有率分析可以对供应商绩效进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV 定位矩阵药物发现资讯学市场供应商的绩效评估

FPNV定位矩阵是评估药物发现资讯学市场供应商的重要工具。此矩阵允许业务组织根据商务策略和产品满意度评估供应商，从而做出与其目标相符的明智决策。这四个象限使您能够清晰、准确地划分供应商，并确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析和建议绘製药物发现资讯学市场的成功之路

药物发现资讯学市场的策略分析对于旨在加强其在全球市场的影响力的公司至关重要。透过审查关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：详细检视当前市场环境、主要企业的广泛资料、评估其在市场中的影响力和整体影响力。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 罕见疾病和不治之症管理中对精准医学的需求不断增加
      • 政府对药物发现程序的有利支持
      • 在药物发现和开发中增加生物资讯软体的使用
    • 抑制因素
      • 开发生物资讯学基础设施需要大量资金
    • 机会
      • 药物发现资讯学发展的潜在研究投资
      • 将下一代技术整合到药物发现过程中
    • 任务
      • 缺乏技术精湛、经验丰富的专业人员
  • 市场区隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章药物发现资讯学市场：按解决方案

  • 服务
  • 软体

第七章按功能分類的药物发现资讯学市场

  • 对接
  • 准备库和资料库
  • 分子建模
  • 定序和目标资料分析

第 8 章药物发现资讯学市场：依最终使用者分类

  • 合约研究组织（CRO）
  • 製药和生物技术公司

第九章药物发现资讯学市场：按应用

  • 药物开发
    • 临床试验
    • 临床前测试
  • 药物发现

第10章美洲药物发现资讯学市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十一章亚太药物发现资讯学市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十二章欧洲、中东和非洲的药物发现资讯学市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十三章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
  • 战略分析和建议

公司名单

  • Accenture PLC
  • Agilent Technologies, Inc.
  • Aragen Life Sciences Ltd.
  • Boehringer Ingelheim International GmbH
  • Cadence Design Systems, Inc.
  • Certara, Inc.
  • Charles River Laboratories International, Inc.
  • ChemAxon Ltd.
  • Cognizant Technology Solutions Corporation
  • Collaborative Drug Discovery, Inc
  • Crown Bioscience, Inc.
  • Dassault Systemes SE
  • Eurofins DiscoverX Products LLC
  • Evotec AG
  • Illumina, Inc.
  • Infosys Limited
  • InSilico Medicine
  • International Business Machines Corporation
  • Jubilant Biosys Ltd.
  • Oracle Corporation
  • PerkinElmer Inc.
  • Schrodinger, Inc.
  • Selvita SA
  • Thermo Fisher Scientific Inc.
  • WuXi AppTec Co., Ltd.
Product Code: MRR-521BAA36EBB5

The Drug Discovery Informatics Market was valued at USD 2.90 billion in 2023, expected to reach USD 3.19 billion in 2024, and is projected to grow at a CAGR of 9.92%, to USD 5.64 billion by 2030.

Drug Discovery Informatics involves applying computational, statistical, and informational techniques to improve the drug discovery process. The necessity arises from the increasing demand for cost-efficient and accelerated drug development processes, as well as the vast complexity involved in targeting biologically active compounds. Its applications span drug target identification, lead discovery, assay development, and virtual screening. In terms of end-use scope, it finds a place in pharmaceutical companies, biotechnology firms, contract research organizations, and academic institutions.

KEY MARKET STATISTICS
Base Year [2023] USD 2.90 billion
Estimated Year [2024] USD 3.19 billion
Forecast Year [2030] USD 5.64 billion
CAGR (%) 9.92%

Market growth is significantly influenced by advancements in big data analytics, AI, and machine learning, which enhance predictive accuracy in drug discovery processes. The surge in personalized medicine and rising adoption of cloud-based solutions contribute further to this growth. Opportunities lie in the integration of AI with informatics for precision medicine, collaborative projects to share molecular data, and expanding into emerging markets. Despite these opportunities, challenges include high costs of informatics tools and data management complexities. Rigorous regulations and data privacy concerns also pose hurdles to market expansion.

Innovation can thrive in areas such as developing intuitive user interfaces for data visualization, streamlining data integration across platforms, and enhancing algorithm robustness for better predictive models. Companies should focus on creating scalable solutions that can continuously adapt to the increasing data volume generated in drug discovery. Collaborating with academic institutes and industry players can also facilitate innovation through shared knowledge and resources.

The market is dynamic and competitive, with numerous players contributing to its rapid evolution. Businesses should prioritize staying at the cutting edge of technology trends, fostering interdisciplinary research, and tailoring informatics solutions to specific therapeutic areas to gain a competitive edge. Through a combination of strategic investments and innovative collaborations, companies can effectively navigate the complexities of drug discovery informatics to foster expansion and market success.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Drug Discovery Informatics Market

The Drug Discovery Informatics Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing need for precision medicine in rare and orphan disease management
    • Favorable government support for drug discovery procedures
    • Rising use of bioinformatic software for drug discovery and development
  • Market Restraints
    • Involvement of huge cost for development of bio-informatic infrastructure
  • Market Opportunities
    • Potential research investments for the development of drug discovery informatics
    • Integration of next-generation technologies in drug discovery procedures
  • Market Challenges
    • Lack of skilled and experienced professionals

Porter's Five Forces: A Strategic Tool for Navigating the Drug Discovery Informatics Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Drug Discovery Informatics Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Drug Discovery Informatics Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Drug Discovery Informatics Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Drug Discovery Informatics Market

A detailed market share analysis in the Drug Discovery Informatics Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Drug Discovery Informatics Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Drug Discovery Informatics Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Drug Discovery Informatics Market

A strategic analysis of the Drug Discovery Informatics Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Drug Discovery Informatics Market, highlighting leading vendors and their innovative profiles. These include Accenture PLC, Agilent Technologies, Inc., Aragen Life Sciences Ltd., Boehringer Ingelheim International GmbH, Cadence Design Systems, Inc., Certara, Inc., Charles River Laboratories International, Inc., ChemAxon Ltd., Cognizant Technology Solutions Corporation, Collaborative Drug Discovery, Inc, Crown Bioscience, Inc., Dassault Systemes SE, Eurofins DiscoverX Products LLC, Evotec AG, Illumina, Inc., Infosys Limited, InSilico Medicine, International Business Machines Corporation, Jubilant Biosys Ltd., Oracle Corporation, PerkinElmer Inc., Schrodinger, Inc., Selvita S.A., Thermo Fisher Scientific Inc., and WuXi AppTec Co., Ltd..

Market Segmentation & Coverage

This research report categorizes the Drug Discovery Informatics Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Solutions, market is studied across Services and Software.
  • Based on Functions, market is studied across Docking, Libraries & Database Preparation, Molecular Modeling, and Sequencing & Target Data Analysis.
  • Based on End-User, market is studied across Contract Research Organizations (CRO) and Pharmaceutical & Biotechnology Companies.
  • Based on Application, market is studied across Drug Development and Drug Discovery. The Drug Development is further studied across Clinical Trials and Preclinical Testing.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing need for precision medicine in rare and orphan disease management
      • 5.1.1.2. Favorable government support for drug discovery procedures
      • 5.1.1.3. Rising use of bioinformatic software for drug discovery and development
    • 5.1.2. Restraints
      • 5.1.2.1. Involvement of huge cost for development of bio-informatic infrastructure
    • 5.1.3. Opportunities
      • 5.1.3.1. Potential research investments for the development of drug discovery informatics
      • 5.1.3.2. Integration of next-generation technologies in drug discovery procedures
    • 5.1.4. Challenges
      • 5.1.4.1. Lack of skilled and experienced professionals
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Drug Discovery Informatics Market, by Solutions

  • 6.1. Introduction
  • 6.2. Services
  • 6.3. Software

7. Drug Discovery Informatics Market, by Functions

  • 7.1. Introduction
  • 7.2. Docking
  • 7.3. Libraries & Database Preparation
  • 7.4. Molecular Modeling
  • 7.5. Sequencing & Target Data Analysis

8. Drug Discovery Informatics Market, by End-User

  • 8.1. Introduction
  • 8.2. Contract Research Organizations (CRO)
  • 8.3. Pharmaceutical & Biotechnology Companies

9. Drug Discovery Informatics Market, by Application

  • 9.1. Introduction
  • 9.2. Drug Development
    • 9.2.1. Clinical Trials
    • 9.2.2. Preclinical Testing
  • 9.3. Drug Discovery

10. Americas Drug Discovery Informatics Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Drug Discovery Informatics Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Drug Discovery Informatics Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
  • 13.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Accenture PLC
  • 2. Agilent Technologies, Inc.
  • 3. Aragen Life Sciences Ltd.
  • 4. Boehringer Ingelheim International GmbH
  • 5. Cadence Design Systems, Inc.
  • 6. Certara, Inc.
  • 7. Charles River Laboratories International, Inc.
  • 8. ChemAxon Ltd.
  • 9. Cognizant Technology Solutions Corporation
  • 10. Collaborative Drug Discovery, Inc
  • 11. Crown Bioscience, Inc.
  • 12. Dassault Systemes SE
  • 13. Eurofins DiscoverX Products LLC
  • 14. Evotec AG
  • 15. Illumina, Inc.
  • 16. Infosys Limited
  • 17. InSilico Medicine
  • 18. International Business Machines Corporation
  • 19. Jubilant Biosys Ltd.
  • 20. Oracle Corporation
  • 21. PerkinElmer Inc.
  • 22. Schrodinger, Inc.
  • 23. Selvita S.A.
  • 24. Thermo Fisher Scientific Inc.
  • 25. WuXi AppTec Co., Ltd.

LIST OF FIGURES

  • FIGURE 1. DRUG DISCOVERY INFORMATICS MARKET RESEARCH PROCESS
  • FIGURE 2. DRUG DISCOVERY INFORMATICS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL DRUG DISCOVERY INFORMATICS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL DRUG DISCOVERY INFORMATICS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL DRUG DISCOVERY INFORMATICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL DRUG DISCOVERY INFORMATICS MARKET SIZE, BY SOLUTIONS, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL DRUG DISCOVERY INFORMATICS MARKET SIZE, BY SOLUTIONS, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL DRUG DISCOVERY INFORMATICS MARKET SIZE, BY FUNCTIONS, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL DRUG DISCOVERY INFORMATICS MARKET SIZE, BY FUNCTIONS, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL DRUG DISCOVERY INFORMATICS MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL DRUG DISCOVERY INFORMATICS MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL DRUG DISCOVERY INFORMATICS MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL DRUG DISCOVERY INFORMATICS MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. AMERICAS DRUG DISCOVERY INFORMATICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. AMERICAS DRUG DISCOVERY INFORMATICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. UNITED STATES DRUG DISCOVERY INFORMATICS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 17. UNITED STATES DRUG DISCOVERY INFORMATICS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC DRUG DISCOVERY INFORMATICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. ASIA-PACIFIC DRUG DISCOVERY INFORMATICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA DRUG DISCOVERY INFORMATICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA DRUG DISCOVERY INFORMATICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. DRUG DISCOVERY INFORMATICS MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 23. DRUG DISCOVERY INFORMATICS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. DRUG DISCOVERY INFORMATICS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL DRUG DISCOVERY INFORMATICS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL DRUG DISCOVERY INFORMATICS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL DRUG DISCOVERY INFORMATICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. DRUG DISCOVERY INFORMATICS MARKET DYNAMICS
  • TABLE 7. GLOBAL DRUG DISCOVERY INFORMATICS MARKET SIZE, BY SOLUTIONS, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL DRUG DISCOVERY INFORMATICS MARKET SIZE, BY SERVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL DRUG DISCOVERY INFORMATICS MARKET SIZE, BY SOFTWARE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL DRUG DISCOVERY INFORMATICS MARKET SIZE, BY FUNCTIONS, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL DRUG DISCOVERY INFORMATICS MARKET SIZE, BY DOCKING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL DRUG DISCOVERY INFORMATICS MARKET SIZE, BY LIBRARIES & DATABASE PREPARATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL DRUG DISCOVERY INFORMATICS MARKET SIZE, BY MOLECULAR MODELING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL DRUG DISCOVERY INFORMATICS MARKET SIZE, BY SEQUENCING & TARGET DATA ANALYSIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL DRUG DISCOVERY INFORMATICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL DRUG DISCOVERY INFORMATICS MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS (CRO), BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL DRUG DISCOVERY INFORMATICS MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL DRUG DISCOVERY INFORMATICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL DRUG DISCOVERY INFORMATICS MARKET SIZE, BY DRUG DEVELOPMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL DRUG DISCOVERY INFORMATICS MARKET SIZE, BY CLINICAL TRIALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL DRUG DISCOVERY INFORMATICS MARKET SIZE, BY PRECLINICAL TESTING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL DRUG DISCOVERY INFORMATICS MARKET SIZE, BY DRUG DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL DRUG DISCOVERY INFORMATICS MARKET SIZE, BY DRUG DISCOVERY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. AMERICAS DRUG DISCOVERY INFORMATICS MARKET SIZE, BY SOLUTIONS, 2018-2030 (USD MILLION)
  • TABLE 25. AMERICAS DRUG DISCOVERY INFORMATICS MARKET SIZE, BY FUNCTIONS, 2018-2030 (USD MILLION)
  • TABLE 26. AMERICAS DRUG DISCOVERY INFORMATICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 27. AMERICAS DRUG DISCOVERY INFORMATICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 28. AMERICAS DRUG DISCOVERY INFORMATICS MARKET SIZE, BY DRUG DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 29. AMERICAS DRUG DISCOVERY INFORMATICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 30. ARGENTINA DRUG DISCOVERY INFORMATICS MARKET SIZE, BY SOLUTIONS, 2018-2030 (USD MILLION)
  • TABLE 31. ARGENTINA DRUG DISCOVERY INFORMATICS MARKET SIZE, BY FUNCTIONS, 2018-2030 (USD MILLION)
  • TABLE 32. ARGENTINA DRUG DISCOVERY INFORMATICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 33. ARGENTINA DRUG DISCOVERY INFORMATICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 34. ARGENTINA DRUG DISCOVERY INFORMATICS MARKET SIZE, BY DRUG DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 35. BRAZIL DRUG DISCOVERY INFORMATICS MARKET SIZE, BY SOLUTIONS, 2018-2030 (USD MILLION)
  • TABLE 36. BRAZIL DRUG DISCOVERY INFORMATICS MARKET SIZE, BY FUNCTIONS, 2018-2030 (USD MILLION)
  • TABLE 37. BRAZIL DRUG DISCOVERY INFORMATICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 38. BRAZIL DRUG DISCOVERY INFORMATICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 39. BRAZIL DRUG DISCOVERY INFORMATICS MARKET SIZE, BY DRUG DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 40. CANADA DRUG DISCOVERY INFORMATICS MARKET SIZE, BY SOLUTIONS, 2018-2030 (USD MILLION)
  • TABLE 41. CANADA DRUG DISCOVERY INFORMATICS MARKET SIZE, BY FUNCTIONS, 2018-2030 (USD MILLION)
  • TABLE 42. CANADA DRUG DISCOVERY INFORMATICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 43. CANADA DRUG DISCOVERY INFORMATICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 44. CANADA DRUG DISCOVERY INFORMATICS MARKET SIZE, BY DRUG DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 45. MEXICO DRUG DISCOVERY INFORMATICS MARKET SIZE, BY SOLUTIONS, 2018-2030 (USD MILLION)
  • TABLE 46. MEXICO DRUG DISCOVERY INFORMATICS MARKET SIZE, BY FUNCTIONS, 2018-2030 (USD MILLION)
  • TABLE 47. MEXICO DRUG DISCOVERY INFORMATICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 48. MEXICO DRUG DISCOVERY INFORMATICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 49. MEXICO DRUG DISCOVERY INFORMATICS MARKET SIZE, BY DRUG DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 50. UNITED STATES DRUG DISCOVERY INFORMATICS MARKET SIZE, BY SOLUTIONS, 2018-2030 (USD MILLION)
  • TABLE 51. UNITED STATES DRUG DISCOVERY INFORMATICS MARKET SIZE, BY FUNCTIONS, 2018-2030 (USD MILLION)
  • TABLE 52. UNITED STATES DRUG DISCOVERY INFORMATICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 53. UNITED STATES DRUG DISCOVERY INFORMATICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 54. UNITED STATES DRUG DISCOVERY INFORMATICS MARKET SIZE, BY DRUG DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 55. UNITED STATES DRUG DISCOVERY INFORMATICS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 56. ASIA-PACIFIC DRUG DISCOVERY INFORMATICS MARKET SIZE, BY SOLUTIONS, 2018-2030 (USD MILLION)
  • TABLE 57. ASIA-PACIFIC DRUG DISCOVERY INFORMATICS MARKET SIZE, BY FUNCTIONS, 2018-2030 (USD MILLION)
  • TABLE 58. ASIA-PACIFIC DRUG DISCOVERY INFORMATICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 59. ASIA-PACIFIC DRUG DISCOVERY INFORMATICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 60. ASIA-PACIFIC DRUG DISCOVERY INFORMATICS MARKET SIZE, BY DRUG DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 61. ASIA-PACIFIC DRUG DISCOVERY INFORMATICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 62. AUSTRALIA DRUG DISCOVERY INFORMATICS MARKET SIZE, BY SOLUTIONS, 2018-2030 (USD MILLION)
  • TABLE 63. AUSTRALIA DRUG DISCOVERY INFORMATICS MARKET SIZE, BY FUNCTIONS, 2018-2030 (USD MILLION)
  • TABLE 64. AUSTRALIA DRUG DISCOVERY INFORMATICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 65. AUSTRALIA DRUG DISCOVERY INFORMATICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 66. AUSTRALIA DRUG DISCOVERY INFORMATICS MARKET SIZE, BY DRUG DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 67. CHINA DRUG DISCOVERY INFORMATICS MARKET SIZE, BY SOLUTIONS, 2018-2030 (USD MILLION)
  • TABLE 68. CHINA DRUG DISCOVERY INFORMATICS MARKET SIZE, BY FUNCTIONS, 2018-2030 (USD MILLION)
  • TABLE 69. CHINA DRUG DISCOVERY INFORMATICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 70. CHINA DRUG DISCOVERY INFORMATICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 71. CHINA DRUG DISCOVERY INFORMATICS MARKET SIZE, BY DRUG DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 72. INDIA DRUG DISCOVERY INFORMATICS MARKET SIZE, BY SOLUTIONS, 2018-2030 (USD MILLION)
  • TABLE 73. INDIA DRUG DISCOVERY INFORMATICS MARKET SIZE, BY FUNCTIONS, 2018-2030 (USD MILLION)
  • TABLE 74. INDIA DRUG DISCOVERY INFORMATICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 75. INDIA DRUG DISCOVERY INFORMATICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 76. INDIA DRUG DISCOVERY INFORMATICS MARKET SIZE, BY DRUG DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 77. INDONESIA DRUG DISCOVERY INFORMATICS MARKET SIZE, BY SOLUTIONS, 2018-2030 (USD MILLION)
  • TABLE 78. INDONESIA DRUG DISCOVERY INFORMATICS MARKET SIZE, BY FUNCTIONS, 2018-2030 (USD MILLION)
  • TABLE 79. INDONESIA DRUG DISCOVERY INFORMATICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 80. INDONESIA DRUG DISCOVERY INFORMATICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 81. INDONESIA DRUG DISCOVERY INFORMATICS MARKET SIZE, BY DRUG DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 82. JAPAN DRUG DISCOVERY INFORMATICS MARKET SIZE, BY SOLUTIONS, 2018-2030 (USD MILLION)
  • TABLE 83. JAPAN DRUG DISCOVERY INFORMATICS MARKET SIZE, BY FUNCTIONS, 2018-2030 (USD MILLION)
  • TABLE 84. JAPAN DRUG DISCOVERY INFORMATICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 85. JAPAN DRUG DISCOVERY INFORMATICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 86. JAPAN DRUG DISCOVERY INFORMATICS MARKET SIZE, BY DRUG DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 87. MALAYSIA DRUG DISCOVERY INFORMATICS MARKET SIZE, BY SOLUTIONS, 2018-2030 (USD MILLION)
  • TABLE 88. MALAYSIA DRUG DISCOVERY INFORMATICS MARKET SIZE, BY FUNCTIONS, 2018-2030 (USD MILLION)
  • TABLE 89. MALAYSIA DRUG DISCOVERY INFORMATICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 90. MALAYSIA DRUG DISCOVERY INFORMATICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 91. MALAYSIA DRUG DISCOVERY INFORMATICS MARKET SIZE, BY DRUG DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 92. PHILIPPINES DRUG DISCOVERY INFORMATICS MARKET SIZE, BY SOLUTIONS, 2018-2030 (USD MILLION)
  • TABLE 93. PHILIPPINES DRUG DISCOVERY INFORMATICS MARKET SIZE, BY FUNCTIONS, 2018-2030 (USD MILLION)
  • TABLE 94. PHILIPPINES DRUG DISCOVERY INFORMATICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 95. PHILIPPINES DRUG DISCOVERY INFORMATICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 96. PHILIPPINES DRUG DISCOVERY INFORMATICS MARKET SIZE, BY DRUG DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 97. SINGAPORE DRUG DISCOVERY INFORMATICS MARKET SIZE, BY SOLUTIONS, 2018-2030 (USD MILLION)
  • TABLE 98. SINGAPORE DRUG DISCOVERY INFORMATICS MARKET SIZE, BY FUNCTIONS, 2018-2030 (USD MILLION)
  • TABLE 99. SINGAPORE DRUG DISCOVERY INFORMATICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 100. SINGAPORE DRUG DISCOVERY INFORMATICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 101. SINGAPORE DRUG DISCOVERY INFORMATICS MARKET SIZE, BY DRUG DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 102. SOUTH KOREA DRUG DISCOVERY INFORMATICS MARKET SIZE, BY SOLUTIONS, 2018-2030 (USD MILLION)
  • TABLE 103. SOUTH KOREA DRUG DISCOVERY INFORMATICS MARKET SIZE, BY FUNCTIONS, 2018-2030 (USD MILLION)
  • TABLE 104. SOUTH KOREA DRUG DISCOVERY INFORMATICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 105. SOUTH KOREA DRUG DISCOVERY INFORMATICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 106. SOUTH KOREA DRUG DISCOVERY INFORMATICS MARKET SIZE, BY DRUG DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 107. TAIWAN DRUG DISCOVERY INFORMATICS MARKET SIZE, BY SOLUTIONS, 2018-2030 (USD MILLION)
  • TABLE 108. TAIWAN DRUG DISCOVERY INFORMATICS MARKET SIZE, BY FUNCTIONS, 2018-2030 (USD MILLION)
  • TABLE 109. TAIWAN DRUG DISCOVERY INFORMATICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 110. TAIWAN DRUG DISCOVERY INFORMATICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 111. TAIWAN DRUG DISCOVERY INFORMATICS MARKET SIZE, BY DRUG DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 112. THAILAND DRUG DISCOVERY INFORMATICS MARKET SIZE, BY SOLUTIONS, 2018-2030 (USD MILLION)
  • TABLE 113. THAILAND DRUG DISCOVERY INFORMATICS MARKET SIZE, BY FUNCTIONS, 2018-2030 (USD MILLION)
  • TABLE 114. THAILAND DRUG DISCOVERY INFORMATICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 115. THAILAND DRUG DISCOVERY INFORMATICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 116. THAILAND DRUG DISCOVERY INFORMATICS MARKET SIZE, BY DRUG DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 117. VIETNAM DRUG DISCOVERY INFORMATICS MARKET SIZE, BY SOLUTIONS, 2018-2030 (USD MILLION)
  • TABLE 118. VIETNAM DRUG DISCOVERY INFORMATICS MARKET SIZE, BY FUNCTIONS, 2018-2030 (USD MILLION)
  • TABLE 119. VIETNAM DRUG DISCOVERY INFORMATICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 120. VIETNAM DRUG DISCOVERY INFORMATICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 121. VIETNAM DRUG DISCOVERY INFORMATICS MARKET SIZE, BY DRUG DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 122. EUROPE, MIDDLE EAST & AFRICA DRUG DISCOVERY INFORMATICS MARKET SIZE, BY SOLUTIONS, 2018-2030 (USD MILLION)
  • TABLE 123. EUROPE, MIDDLE EAST & AFRICA DRUG DISCOVERY INFORMATICS MARKET SIZE, BY FUNCTIONS, 2018-2030 (USD MILLION)
  • TABLE 124. EUROPE, MIDDLE EAST & AFRICA DRUG DISCOVERY INFORMATICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 125. EUROPE, MIDDLE EAST & AFRICA DRUG DISCOVERY INFORMATICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 126. EUROPE, MIDDLE EAST & AFRICA DRUG DISCOVERY INFORMATICS MARKET SIZE, BY DRUG DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 127. EUROPE, MIDDLE EAST & AFRICA DRUG DISCOVERY INFORMATICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 128. DENMARK DRUG DISCOVERY INFORMATICS MARKET SIZE, BY SOLUTIONS, 2018-2030 (USD MILLION)
  • TABLE 129. DENMARK DRUG DISCOVERY INFORMATICS MARKET SIZE, BY FUNCTIONS, 2018-2030 (USD MILLION)
  • TABLE 130. DENMARK DRUG DISCOVERY INFORMATICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 131. DENMARK DRUG DISCOVERY INFORMATICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 132. DENMARK DRUG DISCOVERY INFORMATICS MARKET SIZE, BY DRUG DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 133. EGYPT DRUG DISCOVERY INFORMATICS MARKET SIZE, BY SOLUTIONS, 2018-2030 (USD MILLION)
  • TABLE 134. EGYPT DRUG DISCOVERY INFORMATICS MARKET SIZE, BY FUNCTIONS, 2018-2030 (USD MILLION)
  • TABLE 135. EGYPT DRUG DISCOVERY INFORMATICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 136. EGYPT DRUG DISCOVERY INFORMATICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 137. EGYPT DRUG DISCOVERY INFORMATICS MARKET SIZE, BY DRUG DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 138. FINLAND DRUG DISCOVERY INFORMATICS MARKET SIZE, BY SOLUTIONS, 2018-2030 (USD MILLION)
  • TABLE 139. FINLAND DRUG DISCOVERY INFORMATICS MARKET SIZE, BY FUNCTIONS, 2018-2030 (USD MILLION)
  • TABLE 140. FINLAND DRUG DISCOVERY INFORMATICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 141. FINLAND DRUG DISCOVERY INFORMATICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 142. FINLAND DRUG DISCOVERY INFORMATICS MARKET SIZE, BY DRUG DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 143. FRANCE DRUG DISCOVERY INFORMATICS MARKET SIZE, BY SOLUTIONS, 2018-2030 (USD MILLION)
  • TABLE 144. FRANCE DRUG DISCOVERY INFORMATICS MARKET SIZE, BY FUNCTIONS, 2018-2030 (USD MILLION)
  • TABLE 145. FRANCE DRUG DISCOVERY INFORMATICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 146. FRANCE DRUG DISCOVERY INFORMATICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 147. FRANCE DRUG DISCOVERY INFORMATICS MARKET SIZE, BY DRUG DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 148. GERMANY DRUG DISCOVERY INFORMATICS MARKET SIZE, BY SOLUTIONS, 2018-2030 (USD MILLION)
  • TABLE 149. GERMANY DRUG DISCOVERY INFORMATICS MARKET SIZE, BY FUNCTIONS, 2018-2030 (USD MILLION)
  • TABLE 150. GERMANY DRUG DISCOVERY INFORMATICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 151. GERMANY DRUG DISCOVERY INFORMATICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 152. GERMANY DRUG DISCOVERY INFORMATICS MARKET SIZE, BY DRUG DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 153. ISRAEL DRUG DISCOVERY INFORMATICS MARKET SIZE, BY SOLUTIONS, 2018-2030 (USD MILLION)
  • TABLE 154. ISRAEL DRUG DISCOVERY INFORMATICS MARKET SIZE, BY FUNCTIONS, 2018-2030 (USD MILLION)
  • TABLE 155. ISRAEL DRUG DISCOVERY INFORMATICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 156. ISRAEL DRUG DISCOVERY INFORMATICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 157. ISRAEL DRUG DISCOVERY INFORMATICS MARKET SIZE, BY DRUG DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 158. ITALY DRUG DISCOVERY INFORMATICS MARKET SIZE, BY SOLUTIONS, 2018-2030 (USD MILLION)
  • TABLE 159. ITALY DRUG DISCOVERY INFORMATICS MARKET SIZE, BY FUNCTIONS, 2018-2030 (USD MILLION)
  • TABLE 160. ITALY DRUG DISCOVERY INFORMATICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 161. ITALY DRUG DISCOVERY INFORMATICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 162. ITALY DRUG DISCOVERY INFORMATICS MARKET SIZE, BY DRUG DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 163. NETHERLANDS DRUG DISCOVERY INFORMATICS MARKET SIZE, BY SOLUTIONS, 2018-2030 (USD MILLION)
  • TABLE 164. NETHERLANDS DRUG DISCOVERY INFORMATICS MARKET SIZE, BY FUNCTIONS, 2018-2030 (USD MILLION)
  • TABLE 165. NETHERLANDS DRUG DISCOVERY INFORMATICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 166. NETHERLANDS DRUG DISCOVERY INFORMATICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 167. NETHERLANDS DRUG DISCOVERY INFORMATICS MARKET SIZE, BY DRUG DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 168. NIGERIA DRUG DISCOVERY INFORMATICS MARKET SIZE, BY SOLUTIONS, 2018-2030 (USD MILLION)
  • TABLE 169. NIGERIA DRUG DISCOVERY INFORMATICS MARKET SIZE, BY FUNCTIONS, 2018-2030 (USD MILLION)
  • TABLE 170. NIGERIA DRUG DISCOVERY INFORMATICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 171. NIGERIA DRUG DISCOVERY INFORMATICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 172. NIGERIA DRUG DISCOVERY INFORMATICS MARKET SIZE, BY DRUG DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 173. NORWAY DRUG DISCOVERY INFORMATICS MARKET SIZE, BY SOLUTIONS, 2018-2030 (USD MILLION)
  • TABLE 174. NORWAY DRUG DISCOVERY INFORMATICS MARKET SIZE, BY FUNCTIONS, 2018-2030 (USD MILLION)
  • TABLE 175. NORWAY DRUG DISCOVERY INFORMATICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 176. NORWAY DRUG DISCOVERY INFORMATICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 177. NORWAY DRUG DISCOVERY INFORMATICS MARKET SIZE, BY DRUG DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 178. POLAND DRUG DISCOVERY INFORMATICS MARKET SIZE, BY SOLUTIONS, 2018-2030 (USD MILLION)
  • TABLE 179. POLAND DRUG DISCOVERY INFORMATICS MARKET SIZE, BY FUNCTIONS, 2018-2030 (USD MILLION)
  • TABLE 180. POLAND DRUG DISCOVERY INFORMATICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 181. POLAND DRUG DISCOVERY INFORMATICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 182. POLAND DRUG DISCOVERY INFORMATICS MARKET SIZE, BY DRUG DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 183. QATAR DRUG DISCOVERY INFORMATICS MARKET SIZE, BY SOLUTIONS, 2018-2030 (USD MILLION)
  • TABLE 184. QATAR DRUG DISCOVERY INFORMATICS MARKET SIZE, BY FUNCTIONS, 2018-2030 (USD MILLION)
  • TABLE 185. QATAR DRUG DISCOVERY INFORMATICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 186. QATAR DRUG DISCOVERY INFORMATICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 187. QATAR DRUG DISCOVERY INFORMATICS MARKET SIZE, BY DRUG DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 188. RUSSIA DRUG DISCOVERY INFORMATICS MARKET SIZE, BY SOLUTIONS, 2018-2030 (USD MILLION)
  • TABLE 189. RUSSIA DRUG DISCOVERY INFORMATICS MARKET SIZE, BY FUNCTIONS, 2018-2030 (USD MILLION)
  • TABLE 190. RUSSIA DRUG DISCOVERY INFORMATICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 191. RUSSIA DRUG DISCOVERY INFORMATICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 192. RUSSIA DRUG DISCOVERY INFORMATICS MARKET SIZE, BY DRUG DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 193. SAUDI ARABIA DRUG DISCOVERY INFORMATICS MARKET SIZE, BY SOLUTIONS, 2018-2030 (USD MILLION)
  • TABLE 194. SAUDI ARABIA DRUG DISCOVERY INFORMATICS MARKET SIZE, BY FUNCTIONS, 2018-2030 (USD MILLION)
  • TABLE 195. SAUDI ARABIA DRUG DISCOVERY INFORMATICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 196. SAUDI ARABIA DRUG DISCOVERY INFORMATICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 197. SAUDI ARABIA DRUG DISCOVERY INFORMATICS MARKET SIZE, BY DRUG DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 198. SOUTH AFRICA DRUG DISCOVERY INFORMATICS MARKET SIZE, BY SOLUTIONS, 2018-2030 (USD MILLION)
  • TABLE 199. SOUTH AFRICA DRUG DISCOVERY INFORMATICS MARKET SIZE, BY FUNCTIONS, 2018-2030 (USD MILLION)
  • TABLE 200. SOUTH AFRICA DRUG DISCOVERY INFORMATICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 201. SOUTH AFRICA DRUG DISCOVERY INFORMATICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 202. SOUTH AFRICA DRUG DISCOVERY INFORMATICS MARKET SIZE, BY DRUG DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 203. SPAIN DRUG DISCOVERY INFORMATICS MARKET SIZE, BY SOLUTIONS, 2018-2030 (USD MILLION)
  • TABLE 204. SPAIN DRUG DISCOVERY INFORMATICS MARKET SIZE, BY FUNCTIONS, 2018-2030 (USD MILLION)
  • TABLE 205. SPAIN DRUG DISCOVERY INFORMATICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 206. SPAIN DRUG DISCOVERY INFORMATICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 207. SPAIN DRUG DISCOVERY INFORMATICS MARKET SIZE, BY DRUG DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 208. SWEDEN DRUG DISCOVERY INFORMATICS MARKET SIZE, BY SOLUTIONS, 2018-2030 (USD MILLION)
  • TABLE 209. SWEDEN DRUG DISCOVERY INFORMATICS MARKET SIZE, BY FUNCTIONS, 2018-2030 (USD MILLION)
  • TABLE 210. SWEDEN DRUG DISCOVERY INFORMATICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 211. SWEDEN DRUG DISCOVERY INFORMATICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 212. SWEDEN DRUG DISCOVERY INFORMATICS MARKET SIZE, BY DRUG DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 213. SWITZERLAND DRUG DISCOVERY INFORMATICS MARKET SIZE, BY SOLUTIONS, 2018-2030 (USD MILLION)
  • TABLE 214. SWITZERLAND DRUG DISCOVERY INFORMATICS MARKET SIZE, BY FUNCTIONS, 2018-2030 (USD MILLION)
  • TABLE 215. SWITZERLAND DRUG DISCOVERY INFORMATICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 216. SWITZERLAND DRUG DISCOVERY INFORMATICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 217. SWITZERLAND DRUG DISCOVERY INFORMATICS MARKET SIZE, BY DRUG DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 218. TURKEY DRUG DISCOVERY INFORMATICS MARKET SIZE, BY SOLUTIONS, 2018-2030 (USD MILLION)
  • TABLE 219. TURKEY DRUG DISCOVERY INFORMATICS MARKET SIZE, BY FUNCTIONS, 2018-2030 (USD MILLION)
  • TABLE 220. TURKEY DRUG DISCOVERY INFORMATICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 221. TURKEY DRUG DISCOVERY INFORMATICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 222. TURKEY DRUG DISCOVERY INFORMATICS MARKET SIZE, BY DRUG DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 223. UNITED ARAB EMIRATES DRUG DISCOVERY INFORMATICS MARKET SIZE, BY SOLUTIONS, 2018-2030 (USD MILLION)
  • TABLE 224. UNITED ARAB EMIRATES DRUG DISCOVERY INFORMATICS MARKET SIZE, BY FUNCTIONS, 2018-2030 (USD MILLION)
  • TABLE 225. UNITED ARAB EMIRATES DRUG DISCOVERY INFORMATICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 226. UNITED ARAB EMIRATES DRUG DISCOVERY INFORMATICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 227. UNITED ARAB EMIRATES DRUG DISCOVERY INFORMATICS MARKET SIZE, BY DRUG DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 228. UNITED KINGDOM DRUG DISCOVERY INFORMATICS MARKET SIZE, BY SOLUTIONS, 2018-2030 (USD MILLION)
  • TABLE 229. UNITED KINGDOM DRUG DISCOVERY INFORMATICS MARKET SIZE, BY FUNCTIONS, 2018-2030 (USD MILLION)
  • TABLE 230. UNITED KINGDOM DRUG DISCOVERY INFORMATICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 231. UNITED KINGDOM DRUG DISCOVERY INFORMATICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 232. UNITED KINGDOM DRUG DISCOVERY INFORMATICS MARKET SIZE, BY DRUG DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 233. DRUG DISCOVERY INFORMATICS MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 234. DRUG DISCOVERY INFORMATICS MARKET, FPNV POSITIONING MATRIX, 2023